Somaxon Pharmaceuticals, Inc. 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Jun 5, 2007
Insider Transaction Report
Form 4
Jochelson Philip
Senior VP and Chief Medical
Transactions
- Exercise/Conversion
Common Stock
2007-06-01$2.40/sh+2,275$5,460→ 2,275 total - Sale
Common Stock
2007-06-01$14.67/sh−2,275$33,374→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2007-06-01−2,275→ 29,316 totalExercise: $2.40Exp: 2015-04-02→ Common Stock (2,275 underlying)
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2006, as amended to date.
- [F2]4,489 shares of common stock subject to the option are vested and exercisable as of June 5, 2007 and approximately 1,128 vest and become exercisable on the first day of each month until April 1, 2009.
- [F3]Not applicable.